Abstract:BACKGROUND:Stroke-induced immunodeficiency syndrome (SIDS) is regarded as a protective mechanism for secondary inflammatory injury as well as a contributor to infection complications. Although stroke-induced hyperactivation of the sympathetic system is proved to facilitate SIDS, the involved endogenous factors and pathways are largely elusive. In this study, we aim to investigate the function of beta-arrestin-2 (ARRB2) in the sympathetic-mediated SIDS.METHODS:Splenic ARRB2 expression and the sympathetic system activity were detected after establishing transient models of middle cerebral artery occlusion (MCAO). In addition, a correlation between ARRB2 expression and the sympathetic system activity was analyzed using a linear correlation analysis. Any SIDS reflected in monocyte dysfunction was investigated by measuring inflammatory cytokine secretion and neurological deficit scores and infarct volume were tested to assess neurological outcome. Further, ARRB2 expression in the monocytes was knocked down in vitro by siRNAs. Following the stimulation of noradrenaline and lipopolysaccharide, cytokine secretion and the nuclear factor-κB (NF-κB) pathway were evaluated to gain insight into the mechanisms related to the contribution of ARRB2 to adrenergic-induced monocyte dysfunction.RESULTS:Splenic ARRB2 expression was significantly increased after stroke and also showed a significant positive correlation with the sympathetic system activity. Stroke-induced monocyte dysfunction resulted in an increase of the interleukin-10 (IL-10) level as well as a decrease of the interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) levels. Also, blockade of adrenergic-activity significantly reversed these cytokine levels, and blockade of adrenergic-activity improved stroke-induced neurological results. However, the improved neurological results had no significant correlation with ARRB2 expression. Furthermore, the in vitro results showed that the deficiency of ARRB2 dramatically repealed adrenergic-induced monocyte dysfunction and the inhibition of NF-κB signaling phosphorylation activity.CONCLUSIONS:ARRB2 is implicated in the sympathetic-triggered SIDS, in particular, monocyte dysfunction after stroke. Accordingly, ARRB2 may be a promising therapeutic target for the immunological management of stroke in a clinic.

Role of the Sympathetic Nervous System and Spleen in Experimental Stroke-Induced Immunodepression

Systemic immune responses after ischemic stroke: From the center to the periphery

Augmentation of Peripheral Lymphocyte-Derived Cholinergic Activity in Patients with Acute Ischemic Stroke

Blocking Sympathetic Nervous System Reverses Partially Stroke-Induced Immunosuppression but Does Not Aggravate Functional Outcome after Experimental Stroke in Rats

Splenectomy Protect Experimental Rats From Cerebral Damage After Stroke By Anti-Inflammation

Splenectomy Protects Experimental Rats from Cerebral Damage after Stroke Due to Anti-Inflammatory Effects.

Potential Specific Immunological Indicators for Stroke Associated Infection Are Partly Modulated by Sympathetic Pathway Activation.

The Reciprocal Interaction of Sympathetic Nervous System and Camp-Pka-nf-kb Pathway in Immune Suppression after Experimental Stroke

The “Dialogue” Between Central and Peripheral Immunity After Ischemic Stroke: Focus on Spleen

T Cells Contribute to Stroke-Induced Lymphopenia in Rats.

Quantitative and Correlational Analysis of Brain and Spleen Immune Cellular Responses Following Cerebral Ischemia

Role of Spleen-Derived Monocytes/Macrophages in Acute Ischemic Brain Injury

Targeting Brain-spleen Crosstalk After Stroke: New Insights Into Stroke Pathology and Treatment

Conection of Plasirm Inflammatory Cytokines with the Spleen Weight Index Following Cerebral Ischenda-Reperfusion in Rats

Β-Arrestin2 Functions As a Key Regulator in the Sympathetic-Triggered Immunodepression after Stroke

Experimental Stroke Differentially Affects Discrete Subpopulations of Splenic Macrophages

Correction of plasma inflammatory cytokines with the spleen weight index following cerebral ischemia-reperfusion in rats

Effect of Sympathetic Activity on Peripheral Immune Function of Middle Cerebral Artery Occlusion in Rats

Perspective Review of Myeloid Immune Cell Responses and Poststroke Immunosuppression

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections

Moderate Hypothermia Inhibits Brain Inflammation and Attenuates Stroke‐Induced Immunodepression in Rats